CTOs on the Move

Unum Therapeutics

www.unumrx.com

 
Unum is a Cambridge, MA-based cellular therapeutics company ushering in a new wave of innovation in cancer immunotherapy. Unum has built an antibody-coupled T-cell receptor (ACTR) platform that, when combined with tumor-specific antibodies, directs an individual’s cytotoxic T-lymphocytes (CTLs) to kill tumor cells. In contrast to other approaches that hit a single target and treat a narrow set of tumors, Unum’s approach is not restricted by antigens and may have applications for treating many types of cancers.   Our lead program based on ACTR technology is expected to enter Phase I clinical testing soon to assess safety and efficacy in certain forms ...
  • Number of Employees: 0-25
  • Annual Revenue: $50-100 Million
  • www.unumrx.com
  • One Broadway 4th Floor
    Cambridge, MA USA 02142
  • Phone: 617.843.5032

Executives

Name Title Contact Details

Funding

Unum Therapeutics raised $65M on 06/11/2015

Similar Companies

Balance Pharmaceuticals

Balance Pharmaceuticals is a Pacific Palisades, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MEM SLOAN KETTERING CANCER C

MEM SLOAN KETTERING CANCER C is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Endo

Endo International is a global specialty pharmaceutical company focused on improving patients’ lives while creating value. Endo develops, manufactures, markets and distributes quality branded and generic pharmaceutical products as well as over-the-counter medications through its operating companies – Endo Pharmaceuticals, Par Pharmaceutical, ASTORA Women`s Health, Paladin Labs and SOMAR. Endo commenced operations in 1997 by acquiring certain pharmaceutical products, related rights, and assets from The DuPont Merck Pharmaceutical Company. Since that time, the company has expanded to include the following business segments: U.S. Branded Pharmaceuticals, U.S. Generic Pharmaceuticals, Devices and International Pharmaceuticals. Endo’s strategy is to maximize value for our key stakeholders by employing a lean operating model with focused and disciplined execution that allows us to pursue growth opportunities both organically and through selective acquisitions. Additionally, we are leveraging a research and development model that focuses on lower risk, near-term projects. Our goal is to consistently create value for our shareholders while serving our patients and customers. Endo has global headquarters in Dublin, Ireland and U.S. headquarters in Malvern, Pennsylvania. We employ approximately 6,000 people worldwide*.

Savara Pharmaceuticals

Savara Pharmaceuticals is an emerging specialty pharmaceutical company developing innovative pulmonary drugs for the treatment of serious and life-threatening conditions. The company`s lead product, AeroVanc is the first dry powder inhaled antibiotic for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection in patients with cystic fibrosis (CF).

Paragon Laboratories

Paragon Laboratories is a Torrance, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.